These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Is the pneumococcus the one and only in acute otitis media? Musher D; Dagan R Pediatr Infect Dis J; 2000 May; 19(5):399-400. PubMed ID: 10819333 [No Abstract] [Full Text] [Related]
24. Increasing antibiotic resistance among otitis media pathogens and their susceptibility to oral agents based on pharmacodynamic parameters. Jacobs MR Pediatr Infect Dis J; 2000 May; 19(5 Suppl):S47-55; discussion S55-6. PubMed ID: 10821472 [No Abstract] [Full Text] [Related]
25. Resistant bacteria in middle ear fluid at the time of tympanotomy tube surgery. Sutton DV; Derkay CS; Darrow DH; Strasnick B Ann Otol Rhinol Laryngol; 2000 Jan; 109(1):24-9. PubMed ID: 10651407 [TBL] [Abstract][Full Text] [Related]
26. Comparison of in vitro activities of tigecycline with other antimicrobial agents against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in two university hospitals in Istanbul, Turkey. Gonullu N; Catal F; Kucukbasmaci O; Ozdemir S; Torun MM; Berkiten R Chemotherapy; 2009; 55(3):161-7. PubMed ID: 19390189 [TBL] [Abstract][Full Text] [Related]
27. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. Jacobs MR; Felmingham D; Appelbaum PC; Grüneberg RN; J Antimicrob Chemother; 2003 Aug; 52(2):229-46. PubMed ID: 12865398 [TBL] [Abstract][Full Text] [Related]
28. Antibiotic resistance in pathogens causing acute otitis media in Finnish children. Sillanpää S; Sipilä M; Hyöty H; Rautiainen M; Laranne J Int J Pediatr Otorhinolaryngol; 2016 Jun; 85():91-4. PubMed ID: 27240503 [TBL] [Abstract][Full Text] [Related]
29. Comparative in vitro evaluation of dirithromycin tested against recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae, including effects of medium supplements and test conditions on MIC results. Biedenbach DJ; Jones RN; Lewis MT; Croco MA; Barrett MS Diagn Microbiol Infect Dis; 1999 Apr; 33(4):275-82. PubMed ID: 10212755 [TBL] [Abstract][Full Text] [Related]
30. In vitro activity of faropenem against respiratory pathogens. du Plessis M; Capper TP; Klugman KP J Antimicrob Chemother; 2002 Mar; 49(3):575-7. PubMed ID: 11864964 [No Abstract] [Full Text] [Related]
31. The problem of resistant bacteria for the management of acute otitis media. Barnett ED; Klein JO Pediatr Clin North Am; 1995 Jun; 42(3):509-17. PubMed ID: 7761138 [TBL] [Abstract][Full Text] [Related]
32. Comparative efficacy and safety evaluation of cefaclor vs amoxycillin + clavulanate in children with Acute Otitis Media (AOM). Aggarwal M; Sinha R; Murali MV; Trihan P; Singhal PK Indian J Pediatr; 2005 Mar; 72(3):233-8. PubMed ID: 15812119 [TBL] [Abstract][Full Text] [Related]
33. Effect of prior antibiotic treatment on middle ear disease in children. Faden H; Bernstein J; Brodsky L; Stanievich J; Ogra PL Ann Otol Rhinol Laryngol; 1992 Jan; 101(1):87-91. PubMed ID: 1728891 [TBL] [Abstract][Full Text] [Related]
34. Differences in nasopharyngeal bacterial flora in children with nonsevere recurrent acute otitis media and chronic otitis media with effusion: implications for management. Marchisio P; Claut L; Rognoni A; Esposito S; Passali D; Bellussi L; Drago L; Pozzi G; Mannelli S; Schito G; Principi N Pediatr Infect Dis J; 2003 Mar; 22(3):262-8. PubMed ID: 12634589 [TBL] [Abstract][Full Text] [Related]
35. Susceptibility of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 17 oral antimicrobial agents based on pharmacodynamic parameters: 1998-2001 U S Surveillance Study. Jacobs MR; Bajaksouzian S; Windau A; Good CE; Lin G; Pankuch GA; Appelbaum PC Clin Lab Med; 2004 Jun; 24(2):503-30. PubMed ID: 15177851 [TBL] [Abstract][Full Text] [Related]
36. Host factors and early therapeutic response in acute otitis media. Carlin SA; Marchant CD; Shurin PA; Johnson CE; Super DM; Rehmus JM J Pediatr; 1991 Feb; 118(2):178-83. PubMed ID: 1899699 [TBL] [Abstract][Full Text] [Related]
37. The dynamics of bacteria in the middle ear during the course of acute otitis media with tympanostomy tube otorrhea. Ruohola A; Meurman O; Nikkari S; Skottman T; Heikkinen T; Ruuskanen O Pediatr Infect Dis J; 2007 Oct; 26(10):892-6. PubMed ID: 17901793 [TBL] [Abstract][Full Text] [Related]
38. Investigation about the homogeneity of nasopharyngeal microflora at the different location of nasopharynx of children with acute otitis media. Kaieda S; Yano H; Okitsu N; Hosaka Y; Okamoto R; Inoue M; Takahashi H Int J Pediatr Otorhinolaryngol; 2005 Jul; 69(7):959-63. PubMed ID: 15911015 [TBL] [Abstract][Full Text] [Related]
39. Diagnosis and treatment of otitis media. Ramakrishnan K; Sparks RA; Berryhill WE Am Fam Physician; 2007 Dec; 76(11):1650-8. PubMed ID: 18092706 [TBL] [Abstract][Full Text] [Related]
40. Factors associated with the presence of drug-resistant bacteria and recurrent acute otitis media in children--a study in a private clinic. Kikuta S; Ushio M; Fujimaki Y; Kaga K Acta Otolaryngol Suppl; 2007 Dec; (559):5-8. PubMed ID: 18340553 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]